We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04259944
Recruitment Status : Active, not recruiting
First Posted : February 7, 2020
Last Update Posted : July 27, 2022
Guardant Health, Inc.
Information provided by (Responsible Party):
IFOM, The FIRC Institute of Molecular Oncology

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : July 15, 2024
Estimated Study Completion Date : October 15, 2024